AI assistant
ELI LILLY & Co — Director's Dealing 2019
May 16, 2019
29745_dirs_2019-05-16_288f9e44-29cf-4d79-afe4-6da18646d18b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2019-05-03
Reporting Person: Shaw Christi (SVP and Pres., Lilly Bio-Meds)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-05-03 | Common Stock | S | 7077 | $117.08 | Disposed | 500 | Direct |
Footnotes
F1: This amendment is being filed solely to gain access to the filing system in order to attach the power of attorney authorization. This line item is being re-reported for this purpose.
F2: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 20, 2019.
F3: This transaction was executed in multiple trades at prices ranging from $116.68 to $117.46. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.